| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.21 | 2e-06 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.003 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.098 | 0.004 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.084 | 0.005 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.38 | 0.005 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |